Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases
Tuesday April 25, 2017 3:30 pm to 5:30 pm
Epilepsy/Clinical Neurophysiology (EEG)
Joseph Sirven MD, FAAN
Faculty will use a "headline news" approach to highlight important epilepsy clinical information, and a rapid fire, multi-topic case-based approach with video to provide salient pithy updates on numerous epilepsy topics. Topics will include new treatments, and when to use them; how to manage seizure emergencies; the evidence base for the risks and benefits of cannabis in epilepsy patients; how to approach decisions on devices and diagnosing; and treating immune causes of epilepsy.
Participants should be able list or identify all currently available medication and device treatments for epilepsy; understand the management of acute seizure emergencies; know when to consider immune-based diagnoses and treatments for epilepsy, as well as surgical interventions; know how to counsel on driving laws for epilepsy; and understand where current thought stands on cannabis for epilepsy.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 3:35 PM
Joseph I. Sirven MD, FAAN
3:35 PM - 5:25 PM
Matthew T. Hoerth MD, Joseph I. Sirven MD, FAAN, Angus Wilfong MD
5:25 PM - 5:30 PM
Questions and Answers
Matthew T. Hoerth, MD
Dr. Hoerth has nothing to disclose.
Joseph I. Sirven, MD, FAAN
Dr. Sirven has nothing to disclose.
Angus Wilfong, MD
Dr. Wilfong has received research support from Novartis, Pfizer, UCB, Inc, Upsher-Smith, Lundbeck, GW Pharma, and Eisai.